DCT

1:20-md-02930

In re: Entresto (Sacubitril/Valsartan) Patent Litigation

Please sign up or log in to access the advanced features of
Ex Parte Enterprise.
or Log in
Please sign up or log in to access the advanced features of
Ex Parte Enterprise.
or Log in
Please sign up or log in to access the advanced features of
Ex Parte Enterprise.
or Log in
General
Filed
03/27/20
Cause Of ActionPatent Infringement
SectorBiotech
StatusOpen
Patent Owner
Operating Company (W)
PACER
1:20-md-02930
Nature of Suit835 ANDA
Appeals
24-2209, 
24-2210, 
24-2211, 
24-2212
CourtD. Delaware
Please sign up or log in to access the advanced features of
Ex Parte Professional.
or Log in
Judge
Period
PO Win Rate
Richard G. Andrews
03/15/22 - now
50%
Leonard P. Stark
03/31/20 - 03/15/22
50%
Plaintiff
Please sign up or log in to access the advanced features of
Ex Parte Professional.
or Log in
Party
Name
Ratings
No Parties
Attorney
Name
Ratings
No Plaintiff Attorneys
No Attorneys
Defendant
Please sign up or log in to access the advanced features of
Ex Parte Professional.
or Log in
Party
Name
Ratings
Nanjing Noratech Pharmaceutical Co Ltd 
--
--
--
Gerbera Therapeutics Inc 
--
--
--
No Parties
Attorney
Name
Ratings
Husch Blackwell LLP
L5
A
Patrick J. Coyne
L5
A
Peter Kinsella
L5
A
Heyman Enerio Gattuso & Hirzel LLPLocal
L5
A
Neal S. Cohen
L5
A
Scott E. Holwick
L5
A
No Attorneys